Baker Avenue Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-32,800	Closed	-$489K	–	1592
2023 Q3	$489K	Sell	32,800 -20,000	-38%	-$265K	0.02%	264
2023 Q2	$578K	Hold	52,800	–	–	0.03%	252
2023 Q1	$460K	Hold	52,800	–	–	0.02%	272
2022 Q4	$331K	Hold	52,800	–	–	0.02%	289
2022 Q3	$185K	Hold	52,800	–	–	0.01%	328
2022 Q2	$156K	Hold	52,800	–	–	0.01%	300
2022 Q1	$164K	Buy	+52,800	New	+$166K	0.01%	287
2021 Q3	–	Sell	-52,800	Closed	-$230K	–	280
2021 Q2	$230K	Hold	52,800	–	–	0.01%	225
2021 Q1	$239K	Hold	52,800	–	–	0.02%	219
2020 Q4	$303K	Sell	52,800 -9,700	-16%	-$73.4K	0.02%	198
2020 Q3	$452K	Buy	62,500 +15,000	+32%	+$80.2K	0.03%	171
2020 Q2	$166K	Buy	+47,500	New	+$137K	0.01%	230